Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EBIO – Enthesitis biopsy study
2018-004734-15Phase 4Completed
- Sponsor
- Universitätsklinikum Erlangen
- Start
- May 2019
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, single-arm trial of secukinumab in psoriatic arthritis (PsA), sponsored by Universitätsklinikum Erlangen. Primary endpoint: Reduction in total immune cell numbers in enthesial tissue. Started May 2019; status: completed.
02
Drugs
secukinumab
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on 2018-004734-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2018-004734-15.